ENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02009579 |
|
Recruitment Status :
Active, not recruiting
First Posted : December 12, 2013
Last Update Posted : March 2, 2022
|
Sponsor:
Belgian Gynaecological Oncology Group
Collaborators:
Grupo Español de Investigación en Cáncer de Ovario
Mario Negri Gynecologic Oncology group (MaNGO)
Multicenter Italian Trials in Ovarian Cancer (MITO)
North Eastern German Society of Gynaecological Oncology
Information provided by (Responsible Party):
Belgian Gynaecological Oncology Group
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | January 2021 |
| Estimated Study Completion Date : | October 2023 |